Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial".
作者信息
Tsuda Kazushi
机构信息
Cardiovascular and Metabolic Research Center, Kansai University of Health Sciences, Osaka, Japan.
出版信息
Circulation. 2020 Mar 3;141(9):e100-e101. doi: 10.1161/CIRCULATIONAHA.119.044977. Epub 2020 Mar 2.
Abstract
摘要
Zotero 插件